MN Services Vermogensbeheer’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21M Buy
40,000
+400
+1% +$210K 0.15% 146
2025
Q1
$25.1M Sell
39,600
-2,900
-7% -$1.84M 0.19% 115
2024
Q4
$30.3M Buy
42,500
+1,200
+3% +$855K 0.2% 101
2024
Q3
$43.4M Sell
41,300
-1,000
-2% -$1.05M 0.3% 67
2024
Q2
$44.5M Sell
42,300
-1,000
-2% -$1.05M 0.32% 66
2024
Q1
$41.7M Sell
43,300
-7,400
-15% -$7.12M 0.3% 72
2023
Q4
$44.5M Sell
50,700
-1,800
-3% -$1.58M 0.4% 68
2023
Q3
$43.2M Buy
52,500
+1,300
+3% +$1.07M 0.42% 67
2023
Q2
$36.8M Sell
51,200
-2,000
-4% -$1.44M 0.34% 77
2023
Q1
$43.7M Buy
53,200
+1,900
+4% +$1.56M 0.45% 57
2022
Q4
$37M Sell
51,300
-8,200
-14% -$5.92M 0.41% 61
2022
Q3
$41M Sell
59,500
-3,200
-5% -$2.2M 0.43% 58
2022
Q2
$37.1M Sell
62,700
-12,700
-17% -$7.51M 0.35% 77
2022
Q1
$52.7M Sell
75,400
-4,700
-6% -$3.28M 0.35% 75
2021
Q4
$50.6M Buy
80,100
+1,700
+2% +$1.07M 0.3% 87
2021
Q3
$47.4M Buy
78,400
+1,200
+2% +$726K 0.29% 90
2021
Q2
$36.4M Buy
+77,200
New +$36.4M 0.28% 96
2020
Q4
$36.8M Buy
76,100
+1,300
+2% +$628K 0.26% 101
2020
Q3
$41.9M Buy
74,800
+1,100
+1% +$616K 0.33% 90
2020
Q2
$46M Buy
+73,700
New +$46M 0.39% 74
2019
Q3
Sell
-13,672
Closed -$4.28M 552
2019
Q2
$4.28M Hold
13,672
0.05% 380
2019
Q1
$5.61M Buy
13,672
+200
+1% +$82.1K 0.06% 314
2018
Q4
$4.4M Buy
13,472
+700
+5% +$229K 0.07% 313
2018
Q3
$5.16M Buy
12,772
+300
+2% +$121K 0.12% 187
2018
Q2
$4.3M Hold
12,472
0.11% 208
2018
Q1
$4.3M Buy
12,472
+300
+2% +$103K 0.11% 205
2017
Q4
$3.81M Sell
12,172
-700
-5% -$219K 0.12% 192
2017
Q3
$5.76M Sell
12,872
-200
-2% -$89.4K 0.15% 154
2017
Q2
$6.42M Buy
13,072
+11,001
+531% +$5.4M 0.18% 131
2017
Q1
$750K Sell
2,071
-28
-1% -$10.1K 0.15% 157
2016
Q4
$731K Buy
2,099
+116
+6% +$40.4K 0.15% 156
2016
Q3
$797K Buy
1,983
+34
+2% +$13.7K 0.16% 145
2016
Q2
$613K Buy
1,949
+34
+2% +$10.7K 0.14% 162
2016
Q1
$606K Buy
+1,915
New +$606K 0.14% 162